Customs and Border Protection officers (CPB) in Pennsylvania recently seized Linhua Qingwen capsules. Linhua Qingwen is commonly used for the prevention and treatment of viral influenza in China. It is composed of 11 herbs, gypsum, menthol, and more. The capsules are being sold as a treatment for COVID-19, but their effectiveness is unknown.
Since March 23, CBP officers at the Area Ports of Philadelphia, Baltimore and Washington, and the Ports of Harrisburg and Pittsburgh, completed 18 seizures that collectively included:
– more than 1,350 unapproved and counterfeit COVID-19 test kits;
– nearly 400 counterfeit N95 respirator masks;
– nearly 2,500 unapproved and potentially counterfeit medicines, including Hydroxychloroquine Sulfate, Chloroquine,
– Azithromycin, Lianhua Qingwen and Liushen Jiaonang;
and more than 67,000 counterfeit ACCU-CHEK test strips.
These products were shipped from manufacturers and distributors in China, Hong Kong, South Korea, Turkey, Saudi Arabia, Nigeria, Senegal, Germany and the United Kingdom and were destined to addresses in Pennsylvania, New Jersey, Delaware, Virginia, Connecticut, and Florida.
Source : www.news.yahoo.comBack to previous